Olink

Olink®
Part of Thermo Fisher Scientific

Olink Proteomics World

Join us on September 26, 2024 to learn more about proteomics in drug development, biomarker discovery & clinical translation, and proteogenomics.

Register Now

Olink Explore HT

Measure 5,400+ proteins with proven specificity to gain an understanding of disease at the protein level.

Olink Explore HT

A significant milestone in proteomics research

The number of peer-reviewed scientific articles citing Olink now exceeds 2,000, revealing interesting recent trends in protein biomarker research.

Read more

OlinkOlink Target 48

New Immune Surveillance panel now available. Perform immune biomarker profiling with absolute confidence.

Learn more

OlinkOlink Insight

Journey from experiment planning and study design to post-run data analysis – in a single online bioinformatic app.

Learn moreSign up free

Landmark articles in Nature 
show the power of population-scale proteogenomics

Publications

Read the latest impressive findings from the UK Biobank Pharma Proteomics Project.

Learn more

Empowering genomics with high-throughput proteomics

E-book

Explore recent advancements in our pioneering field. Discover how top scientists use high-throughput proteomics to advance precision medicine.

Learn more

One platform. 
Endless possibilities.

PEA Technology

Meet the next-generation proteomics platform trusted by small lab teams and leading pharma companies.

Learn more

Latest news

Stay updated with the latest Olink news, including press releases, events, and notable publications describing cutting-edge research and key advancements in proteomics.

Blog

UK Biobank Population-level Studies Using Olink’s PEA Technology Advance Disease Understanding and Therapy Development

Explore the transformative potential of integrating proteomics with genomics. Dr. Ryan Dhindsa’s research with UK Biobank data using Olink’s PEA technology identifies thousands of rare genotype-protein associations, revealing new disease-associated genes and therapeutic targets.

Read more

Press release

Olink Insight Unveils Open-access Map of the Human Proteome, Aiding Biomarker Discovery and Understanding of Disease

Olink announces the availability of an open-access data library consisting of over 300,000 protein-disease risk associations, giving researchers a powerful new tool for revealing the biological mechanisms underlying 106 human diseases.

read more

Olink is now part of Thermo Fisher Scientific

Learn More